Effect of WeiJia on carbon tetrachloride induced chronic liver injury

World Journal of Gastroenterology

Volumn 12, Issue 12, 2006, Pages 1912-1917

  Cheung, Pik Yuen ^a   Zhang, Qi ^a   Zhang, Ya Ou ^b   Bai, Gan Rong ^a   Lin, Marie Chia Mi ^c   Chan, Bernard ^d   Fong, Chi Chun ^a   Shi, Lin ^a   Shi, Yue Feng ^a   Chun, Jay ^d   Kung, Hsiang Fu ^e   Yang, Meng Su ^a  

^a CITY UNIVERSITY OF HONG KONG   (Hong Kong)

^b TSINGHUA UNIVERSITY   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d LifeTec Enterprise Limited   (Hong Kong)

^e and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

Carbon tetrachloride; Liver fibrosis; WeiJia

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA SMOOTH MUSCLE ACTIN; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; CHINESE DRUG; COLLAGEN TYPE 4; CYCLINE; GAMMA GLUTAMYLTRANSFERASE; HYALURONIC ACID; OLIVE OIL; UNCLASSIFIED DRUG; WEIJIA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL ACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE MARKER; DISEASE MODEL; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; FEMALE; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; LIVER FIBROSIS; LIVER FUNCTION; LIVER INJURY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; STELLATE CELL; TREATMENT OUTCOME;

EID: 33645963113     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i12.1912     Document Type: Article

References (36)

1. Lin KW, Kirchner JT. Hepatitis B. Am Fam Physician 2004; 69:75-82
2. Lai CL, Ratziu V, Yuen W, Poynard T. Viral hepatitis B. Lancet 2003; 362: 2089-2094
3. McHutchison JG. Understanding hepatitis C. Am J Manag Care 2004; 10(2 Suppl): S21-S29
4. Poynard T, Yuen MF, Ratziu V, Lai CL. Viral hepatitis C. Lancet 2003; 362: 2095-2100
5. McClain CJ, Song Z, Barve SS, Hill DB, Deaciuc I. Recent advances in alcoholic liver disease. IV. Dysregulated cytokine metabolism in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 2004; 287: G497-G502
6. Lotersztajn S, Julien B, Teixeira-Clerc F, Grenard P, Mallat A. Hepatic fibrosis: molecular mechanisms and drug targets. Annu Rev Pharmacol Toxicol 2005; 45: 605-628
7. Eng FJ, Friedman SL. Fibrogenesis I. New insights into hepatic stellate cell activation: the simple becomes complex. Am J Physiol Gastrointest Liver Physiol 2000; 279: G7-G11
8. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000; 275: 2247-2250
9. Iredale JP. Hepatic stellate cell behavior during resolution of liver injury. Semin Liver Dis 2001; 21: 427-436
10. Yu YY, Si CW, Zeng Z, Wang QH, Luo RD, Zhou YL, Zeng MD, Qiao GY, Yao JL, Chan WL. Clinical research of intravenation of hepatocyte growth promoting factors on hepatitis gravis. J Clin Intern Med 2002; 19: 255-257
11. Fang H, Xu XJ, Zhou RG. Clinical analysis of hepatocyte growth promoting factors effect on 60 severe chronic hepatitis patients. J Clin Intern Med 2002; 19: 474
12. Gu WF, Hu XJ, He LM, Wang ZH. Analysis of the therapeutic effect of "weijia" in severe chronic B type viral hepatitis. Linchuang Gandanbing Zazhi 2003; 19: 39-40
13. Zhong LH, Lu BL Fan Y. The therapeutic effect of hepatocyte growth factor (HGF) in liver cirrhosis after hepatitis. Zhongguo Shenghua Yaowu Zazhi 2002; 23:308-309
14. Koenigs JW. Hydrogen peroxide and iron: a microbial cellulolytic system? Biotechnol Bioeng Symp 1975; 151-159
15. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994; 20: 15-20
16. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24: 289-293
17. Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 1705-1725
18. Olga OZ, Nikolai DY. Invasive and non-invasive monitoring of hepatitis C virus-induced liver fibrosis: alternatives or complements? Curr Pharm Biotechnol 2003; 4: 195-209
19. Afdhal NH, Nunes D. Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 2004; 99: 1160-1174
20. Abbasciano V, Levato F, Zavagli G. Specificity of tumor markers (CEA, GICA, TPA, alpha-FP, FpA, gamma-GT) for the diagnosis of hepatic metastases from large bowel cancers. Med Oncol Tumor Pharmacother 1989; 6:129-132
21. Bonacini M, Hadi G, Govindarajan S, Lindsay KL. Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol 1997; 92: 1302-1304
22. Imperiale TF, Said AT, Cummings OW, Born LJ. Need for validation of clinical decision aids: use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C. Am J Gastroenterol 2000; 95: 2328-2332
23. Giannini E, Risso D, Botta F, Chiarbonello B, Fasoli A, Malfatti F, Romagnoli P, Testa E, Ceppa. P, Testa R. Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with he atitis C virus-related chronic liver disease. Arch Intern Med 2003; 163: 218-224
24. Nakamura T, Hayama M, Sakai T, Hotchi M, Tanaka E. Proliferative activity of hepatocytes in chronic viral hepatitis as revealed by immnunohistochemistry for proliferating cell nuclear antigen. Hum Pathol 1993; 24: 750-753
25. Zajicek G, Oren R, Weinreb M Jr. The streaming liver. Liver 1985; 5: 293-300
26. Jezequel AM, Paolucci F, Benedetti A, Mancini R, Orlandi F. Enumeration of S-phase cells in normal rat liver by immunohistochemistry using bromodeoxyuridine-antibromodeoxyuridine system. Dig Dis Sci 1991; 36: 482-484
27. Fausto N. Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells. Hepatology 2004; 39: 1477-1487
28. Ballardini G, Groff P, Zoh M, Bianchi G, Giostra F, Francesconi R, Lenzi M, Zauli D, Cassani F, Bianchi F. Increased risk of hepatocellular carcinoma development in patients with cirrhosis and with high hepatocellular proliferation. J Hepatol 1994; 20: 218-222
29. Kawakita N, Seki S, Sakaguchi H, Yanai A, Kuroki T, Mizoguchi Y, Kobayashi K, Monna T. Analysis of proliferating hepatocytes using a monoclonal antibody against proliferating cell nuclear antigen/cyclin in embedded tissues from various liver diseases fixed in formaldehyde. Am J Pathol 1992; 140: 513-520
30. Seki S, Sakaguchi H, Kawakita N, Yanai A, Kuroki T, Mizoguchi Y, Kobayashi K, Monna T. Detection of proliferating liver cells in various diseases by a monoclonal antibody against DNA polymerase-alpha: with special reference to the relationship between hepatocytes and sinusoidal cells. Hepatology 1991; 14: 781-788
31. Koukoulis G, Rayner A, Tan KC, Williams R, Portmarm B. Immunolocalization of regenerating cells after submassive liver necrosis using PCNA staining. J Pathol 1992; 166: 359-368
32. Ojanguren I, Ariza A, Llatjos M, Castella E, Mate JL, Navas-Palacios JJ. Proliferating cell nuclear antigen expression in normal, regenerative, and neoplastic liver: a fine-needle aspiration cytology and biopsy study. Hum Pathol 1993; 24: 905-908
33. Paradis V, Youssef N, Dargere D, Ba N, Bonvoust F, Deschatrette J, Bedossa P. Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas. Hum Pathol 2001; 32: 327-332
34. Falkowski O, An HJ, Ianus IA, Chiriboga L, Yee H, West AB, Theise ND. Regeneration of hepatocyte 'buds' in cirrhosis from intrabiliary stem cells. J Hepatol 2003; 39: 357-364
35. Rudolph KL, Chang S, Millard M, Schreiber-Agus N, DePinho RA. Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery. Science 2000; 287: 1253-1258
36. Senoo H. Structure and function of hepatic stellate cells. Med Electron Microsc 2004; 37: 3-15